BX Swiss TOP 30 CHF
1.280,68
PKT
+4,17
PKT
+0,33
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.01.15 | UBS buy | Deutsche Bank AG | |
| 23.01.15 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.01.15 | UBS buy | Citigroup Corp. | |
| 23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.15 | Roche Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis buy | UBS AG | |
| 22.01.15 | Roche Neutral | UBS AG | |
| 22.01.15 | Swiss Re neutral | Barclays Capital | |
| 22.01.15 | Zurich Insurance Equal weight | Barclays Capital | |
| 22.01.15 | UBS Halten | Bankhaus Lampe KG | |
| 22.01.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 22.01.15 | Holcim buy | Jefferies & Company Inc. | |
| 22.01.15 | Holcim Underweight | HSBC | |
| 21.01.15 | Novartis neutral | Morgan Stanley | |
| 21.01.15 | UBS Neutral | UBS AG | |
| 21.01.15 | Holcim Neutral | BNP PARIBAS | |
| 21.01.15 | Holcim Neutral | BNP PARIBAS | |
| 21.01.15 | UBS neutral | Independent Research GmbH | |
| 21.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 21.01.15 | Givaudan Outperform | Credit Suisse Group | |
| 20.01.15 | Novartis Equal-Weight | Morgan Stanley | |
| 20.01.15 | Holcim Neutral | UBS AG | |
| 20.01.15 | Holcim Neutral | UBS AG | |
| 20.01.15 | Roche kaufen | Morgan Stanley | |
| 20.01.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 20.01.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 20.01.15 | UBS Halten | Independent Research GmbH | |
| 20.01.15 | Novartis neutral | Independent Research GmbH | |
| 20.01.15 | ABB (Asea Brown Boveri) Neutral | Citigroup Corp. | |
| 20.01.15 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.15 | Givaudan Underweight | Barclays Capital | |
| 19.01.15 | ABB (Asea Brown Boveri) buy | S&P Capital IQ | |
| 19.01.15 | Holcim buy | S&P Capital IQ | |
| 19.01.15 | UBS Neutral | UBS AG | |
| 19.01.15 | Givaudan buy | UBS AG | |
| 19.01.15 | Roche kaufen | Independent Research GmbH | |
| 19.01.15 | UBS buy | S&P Capital IQ | |
| 19.01.15 | Nestlé Reduce | Nomura |